APA (7th ed.) Citation

Bear, H. D., Wan, W., Robidoux, A., Rubin, P., Limentani, S., White, R. L., . . . Sing, A. P. (2017). Using the 21‐gene assay from core needle biopsies to choose neoadjuvant therapy for breast cancer: A multicenter trial. Journal of surgical oncology, 115(8), 917-923. https://doi.org/10.1002/jso.24610

Chicago Style (17th ed.) Citation

Bear, Harry D., et al. "Using the 21‐gene Assay from Core Needle Biopsies to Choose Neoadjuvant Therapy for Breast Cancer: A Multicenter Trial." Journal of Surgical Oncology 115, no. 8 (2017): 917-923. https://doi.org/10.1002/jso.24610.

MLA (9th ed.) Citation

Bear, Harry D., et al. "Using the 21‐gene Assay from Core Needle Biopsies to Choose Neoadjuvant Therapy for Breast Cancer: A Multicenter Trial." Journal of Surgical Oncology, vol. 115, no. 8, 2017, pp. 917-923, https://doi.org/10.1002/jso.24610.